These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 2865933

  • 1. Mechanism of the hypotensive effect of a novel phenylpiperazine derivative, SGB-1534: antagonism at alpha 1-adrenergic and 5-HT2 receptors.
    Aono J, Nabata H, Ishizuka N, Sakai K.
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):126-39. PubMed ID: 2865933
    [Abstract] [Full Text] [Related]

  • 2. [The hypotensive effects and mechanism of SGB-483, a newly-synthesized hypotensive agent].
    Chin W, Nakagawa Y, Mitomi A, Imai S.
    Nihon Yakurigaku Zasshi; 1982 May; 79(5):441-9. PubMed ID: 6127291
    [Abstract] [Full Text] [Related]

  • 3. Effects of a new antihypertensive agent, SGB-1534, on rat platelet aggregation.
    Aono J, Sakai K.
    Jpn J Pharmacol; 1986 Dec; 42(4):493-500. PubMed ID: 2879951
    [Abstract] [Full Text] [Related]

  • 4. Investigations into the mechanism of the antihypertensive effect of SGB-1534, a novel alpha 1-adrenoceptor antagonist, in rats.
    Aono J, Sakai K.
    Jpn J Pharmacol; 1988 Oct; 48(2):229-39. PubMed ID: 2905394
    [Abstract] [Full Text] [Related]

  • 5. Antihypertensive effects of a novel phenylpiperazine derivative, SGB-1534, on several hypertensive models of rats.
    Nabata H, Aono J, Ishizuka N, Sakai K.
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):104-18. PubMed ID: 3904651
    [Abstract] [Full Text] [Related]

  • 6. Characterization of a novel alpha 1-adrenoceptor antagonist, SGB-1534, in contractile response of isolated canine arterial and venous smooth muscle to exogenous noradrenaline: comparison with prazosin, phentolamine and yohimbine.
    Koga T, Shiraki Y, Sakai K.
    Jpn J Pharmacol; 1989 Jun; 50(2):185-93. PubMed ID: 2570173
    [Abstract] [Full Text] [Related]

  • 7. Alpha-adrenoceptor antagonistic effects and antihypertensive activity of SGB-1534 in conscious normotensive and deoxycorticosterone acetate (DOCA)-salt hypertensive dogs: comparison with prazosin.
    Haruta K, Baba A, Akima M, Koga T, Shiraki Y, Sakai K.
    Arch Int Pharmacodyn Ther; 1989 Jun; 299():169-84. PubMed ID: 2570554
    [Abstract] [Full Text] [Related]

  • 8. Differential vasomotor action of noradrenaline, serotonin, and histamine in isolated basilar artery from rat and guinea-pig.
    Chang JY, Hardebo JE, Owman C.
    Acta Physiol Scand; 1988 Jan; 132(1):91-102. PubMed ID: 2906211
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological profile of a new 5-hydroxytryptamine2 receptor antagonist, DV-7028.
    Shibano T, Tanaka T, Morishima Y, Yasuoka M, Watanabe K, Fujii F.
    Arch Int Pharmacodyn Ther; 1992 Jan; 319():114-28. PubMed ID: 1285670
    [Abstract] [Full Text] [Related]

  • 10. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.
    Van Nueten JM, Janssen PA, Van Beek J, Xhonneux R, Verbeuren TJ, Vanhoutte PM.
    J Pharmacol Exp Ther; 1981 Jul; 218(1):217-30. PubMed ID: 6113280
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive properties of ketanserin (R 41 468).
    Vanhoutte PM, Van Nueten JM, Symoens J, Janssen PA.
    Fed Proc; 1983 Feb; 42(2):182-5. PubMed ID: 6295821
    [Abstract] [Full Text] [Related]

  • 12. In vivo and in vitro pharmacological studies of a new hypotensive compound (QF0301B) in rat: comparison with prazosin, a known alpha1-adrenoceptor antagonist.
    Orallo F, Garcia-Ferreiro T, Enguix MJ, Tristan H, Masaguer C, Ravina E, Cadavid I, Loza MI.
    Vascul Pharmacol; 2003 Feb; 40(2):97-108. PubMed ID: 12646398
    [Abstract] [Full Text] [Related]

  • 13. Role of 5-HT2 receptors in serotonin-induced contractions of nonvascular smooth muscle.
    Cohen ML, Schenck KW, Colbert W, Wittenauer L.
    J Pharmacol Exp Ther; 1985 Mar; 232(3):770-4. PubMed ID: 3973826
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological profile of a new potent 5-hydroxytryptamine (5-HT2) alpha 1-receptor antagonist.
    Schröder G, Beckmann R, Gerbling KP, Loge O, Maass B, Müller B, Seidelmann D, Schneider HH, Schulz BG, Stürzebecher CS.
    Arzneimittelforschung; 1988 Jun; 38(6):765-70. PubMed ID: 2902861
    [Abstract] [Full Text] [Related]

  • 15. Potent alpha-adrenoceptor blocking action of SGB-1534, a new quinazoline antihypertensive agent in vitro experiments.
    Shibata S, Satake N, Suh TK, Ishida Y, Ueda S, Follmer C, Flores F.
    Gen Pharmacol; 1986 Jun; 17(2):143-9. PubMed ID: 2870954
    [Abstract] [Full Text] [Related]

  • 16. Alpha-blocking potencies of antihypertensive agents (prazosin, terazosin, bunazosin, SGB-1534 and ketanserin) having with quinazoline or quinazolinedione as assessed by radioligand binding assay methods in rat brain.
    Tsuchihashi H, Nagatomo T.
    J Pharmacobiodyn; 1989 Mar; 12(3):170-4. PubMed ID: 2569512
    [Abstract] [Full Text] [Related]

  • 17. Receptor mechanisms for 5-hydroxytryptamine in isolated human umbilical artery and vein.
    Tuncer M, Doğan N, Oktay S, Kayaalp SO.
    Arch Int Pharmacodyn Ther; 1985 Jul; 276(1):17-27. PubMed ID: 2864904
    [Abstract] [Full Text] [Related]

  • 18. The subtype of serotonin (5-HT) receptors in the rat pulmonary artery.
    Uma S, Tuncer M, Kayaalp SO.
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):248-55. PubMed ID: 3675084
    [Abstract] [Full Text] [Related]

  • 19. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML, Schenck KW, Kurz KD.
    J Cardiovasc Pharmacol; 1988 Aug; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [Abstract] [Full Text] [Related]

  • 20. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
    Centurión D, Mehotra S, Sánchez-López A, Gupta S, MaassenVanDenBrink A, Villalón CM.
    Eur J Pharmacol; 2006 Mar 27; 535(1-3):234-42. PubMed ID: 16545797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.